Yanfeng Xi
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 22
- Cancer Immunotherapy and Biomarkers 7
- HER2/EGFR in Cancer Research 4
-
- Circular RNAs in diseases 4
- Co-authors
- Jing Xu (2 shared papers)Jing Li (1 shared paper)Kun Yang (1 shared paper)Lijun Yang (4 shared papers)Tao Yang (4 shared papers)He Wu (1 shared paper)Enwei Xu (6 shared papers)Jian Wang (1 shared paper)
- Journals
- Transplant Immunology (4 papers)Journal of Cancer Research and Clinical Oncology (4 papers)Tumor Biology (3 papers)The FASEB Journal (2 papers)BioMed Research International (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yanfeng Xi
73 papers receiving 744 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 142
- Oncology 218
- Immunology 111
- Pathology and Forensic Medicine 88
- Molecular Biology 223
Countries citing papers authored by Yanfeng Xi
This map shows the geographic impact of Yanfeng Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfeng Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfeng Xi more than expected).
Fields of papers citing papers by Yanfeng Xi
This network shows the impact of papers produced by Yanfeng Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfeng Xi. The network helps show where Yanfeng Xi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanfeng Xi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 67 | |
| 2 | 2018 | 44 | |
| 3 | 2021 | 36 | |
| 4 | 2018 | 33 | |
| 5 | 2019 | 29 | |
| 6 | 2019 | 26 | |
| 7 | 2023 | 26 | |
| 8 | 2021 | 26 | |
| 9 | 2018 | 25 | |
| 10 | 2018 | 25 | |
| 11 | 2016 | 24 | |
| 12 | 2019 | 24 | |
| 13 | 2023 | 24 | |
| 14 | Correlations between expression levels of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase, and efficacy of 5-fluorouracil-based chemotherapy for advanced colorectal cancer. | 2015 | 21 |
| 15 | 2012 | 18 | |
| 16 | 2019 | 17 | |
| 17 | 2018 | 15 | |
| 18 | 2011 | 14 | |
| 19 | 2022 | 13 | |
| 20 | 2016 | 13 |
About Yanfeng Xi
Yanfeng Xi is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 78 papers that have together received 748 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Cancer-related molecular mechanisms research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (7 papers), Genetic factors in colorectal cancer (6 papers), HER2/EGFR in Cancer Research (4 papers), Immunotherapy and Immune Responses (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (142 citations), Oncology (218 citations), Immunology (111 citations), Pathology and Forensic Medicine (88 citations) and Molecular Biology (223 citations). Yanfeng Xi has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Jing Xu, Jing Li, Kun Yang, Lijun Yang, Tao Yang, He Wu, Enwei Xu, Jian Wang, Hong Li and Gao‐Jun Teng. Their work appears in journals such as Transplant Immunology, Journal of Cancer Research and Clinical Oncology, Tumor Biology, The FASEB Journal and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.